3 Shares Falling Today: Capita PLC, Rare Earth Minerals PLC And Proteome Sciences plc

These three shares are firmly in the red: Capita PLC (LON: CPI), Rare Earth Minerals PLC (LON: REM) and Proteome Sciences plc (LON: PRM)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Capita

Shares in Capita (LSE: CPI) fell by more than 7% today, with investor sentiment in the company declining as doubts continue regarding its bid pipeline and contract losses. Indeed, Capita has secured £1.6 billion of contracts so far this year, which is well behind the figure of £2.9 billion from the same time last year, with its bid pipeline also down at £4.1 billion from £5.7 billion at the same time last year.

Despite this, Capita has stated that it remains on track to meet full-year expectations, which include a 100% cash conversion rate. Furthermore, additional acquisitions are planned and, together with organic growth, means that Capita is set to post earnings growth of 8% in each of the next two years. With shares in the company trading on a price to earnings (P/E) ratio of 16.2, though, they still seem to be rather richly priced even after today’s share price fall.

Rare Earth Minerals

Shares in Rare Earth Minerals (LSE: REM) dropped down 4% this morning despite the company releasing encouraging news regarding its Yangibana project in Western Australia. Indeed, the mineral resource at the project has more than doubled, with the total mineral resource of rare earth oxides increasing to 103,000 contained tonnes, up from the previous 45,000 contained tonnes.

Furthermore, Rare Earth Minerals also announced that recently taken aerial photography also shows that mineralisation continues to the west of Yangibana North, which could provide the opportunity for additional shallow mineralisation to take place.

In addition, the company also announced today that it is assessing its strategic options in the development of its interest in two joint ventures (Fleur-El Sauz and Megalit), as well as increasing its stake in its joint venture partner in the Sonora Lithium Project in Mexico, with its holding in Bacanora now being 12%.

Therefore, the share price fall of Rare Earth Minerals today could be due to profit taking, since news flow seems to be encouraging.

Proteome Sciences

A 15%+ fall in the share price of Proteome Sciences (LSE: PRM) has taken place today, with the protein biomarker company announcing that full-year revenue will not meet market expectations.

The reason for this is further contract delays, some of which were highlighted in its September interims, with Proteome not expecting to realise the revenue next year, either. The result is a top line that looks set to be below last year’s level and weak sentiment in the company’s shares.

Although there could be more positive news on the horizon, with Proteome currently in talks to out-license diagnostic applications for the detection of Alzheimer’s disease and cognitive impairments, sentiment could weaken further due to the relatively large degree of uncertainty surrounding the company’s near-term prospects. As such, further share price falls could take place until more detail is provided regarding future sales levels.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »